SCHOLARLY PUBLICATION
✓ Open Access
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
📄 Abstract
Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
📤 Share this page
Found this useful? Share it with your network.